Work

Treatment with tebentafusp beyond radiographic progressive disease (PD) in metastatic uveal melanoma (mUM).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.9585

Authors: Ryan J. Sullivan, Mohammed M. Milhem, Lev V. Demidov, Karl D. Lewis, Max Schlaak, Sophie Piperno-Neumann, Shaad Essa Abdullah, Claire Watkins, Howard Goodall, John M. Kirkwood

Institutions: Massachusetts General Hospital, University of Iowa Hospitals and Clinics, Russian Cancer Research Center NN Blokhin, University of Colorado Cancer Center, LMU Klinikum, Ludwig-Maximilians-Universität München, Institut Curie, Immunocore (United Kingdom), University of Pittsburgh Medical Center

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281911799

Cites:

Cited by: 10

Related to: 10